Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
BIOTRICITY INC.
Next earnings ≈ Aug 14, 2026 · est. from filing cadence
Last earnings -2.4% on 2026-02-18
Revenue grew 14.3% YoY; but unprofitable (net margin -61.1%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
BIOTRICITY INC. shows $13.8M in FY2025 revenue (+14.3% YoY), a -61.1% net margin, and 26.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001630113, latest 10-Q filed 2026-02-11) · EODHD · rules-based read · as of 6/18/2026, 1:09:19 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.38M | $7.65M | $9.64M | $12.1M | $13.8M |
| Gross profit | $1.27M | $4.57M | $5.44M | $8.36M | $10.6M |
| Operating income | — | -$16.7M | -$15.4M | -$8.83M | -$2.45M |
| Net income | -$15.5M | -$29.1M | -$18.7M | -$14.1M | -$8.42M |
| Diluted EPS | — | — | -$2.26 | -$1.66 | -$0.56 |
| Net margin | -457.7% | -380.8% | -193.6% | -116.8% | -61.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
| 2021-11-29 | Betts Norman M. Director | Award | 54.3K | |
| 2021-11-29 | Rosa David A Director | Award | 27.2K | |
| 2021-10-11 | Rosa David A Director | Sell | 3.32K @ $3.05 | $10.1K |
| 2021-10-08 | Rosa David A Director | Sell | 9.48K @ $3.20 | $30.3K |
| 2021-10-07 | Rosa David A Director | Sell | 17.2K @ $3.08 | $53.1K |
| 2021-09-16 | Rosa David A Director | Sell | 35.0K @ $3.43 | $120K |
| 2021-09-15 | Rosa David A Director | Sell | 6.25K @ $3.27 | $20.4K |